Condition
Growth Retardation, Intrauterine
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Blood Test
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Blood Test1
- Urine Test1
Active Sponsors
- Centre Hospitalier Universitaire de Nīmes1
Top Investigators
Centre Hospitalier Universitaire de Nīmes
Centre Hospitalier Universitaire de Nīmes
Centre Hospitalier Universitaire de Nīmes
Centre Hospitalier Universitaire de Nīmes
Centre Hospitalier Universitaire de Nīmes
Related Conditions
- Preeclampsia1
- Pregnancy Complications1